A virtual triage service launched during COVID-19 lockdown by skin cancer diagnostics service MoleMap has identified skin cancer in 12 per cent of high-risk patients examined.

The new contactless service was used by melanographers in New Zealand and Australia to assess patient lesions remotely and refer high priority cases for further diagnosis and treatment during lockdown.